The value of serum procalcitonin in differential diagnosis of pulmonary embolism and community-acquired pneumonia

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 5, 2011, Pages 519-525

  Köktürk, Nurdan ^a   Kanbay, Asiye ^a   Bukan, Neslihan ^a   Ekim, Numan ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

C reactive protein; interleukin 6; pneumonia; procalcitonin; pulmonary embolism; tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; COUMARIN; HEPARIN; INTERLEUKIN 6; LOW MOLECULAR WEIGHT HEPARIN; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FEVER; HUMAN; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ANTI-INFECTIVE AGENTS; ANTICOAGULANTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; COMMUNICABLE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PNEUMONIA; PROTEIN PRECURSORS; PULMONARY EMBOLISM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053583342     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029610375425     Document Type: Article

References (30)

1. Söderberg M, Hedström S, Sjunnesson M, Lärfars G, Jorup-Rönström C. Initial symptoms in pulmonary embolism differ from those in pneumonia: a retrospective study during seven years. Eur J Emerg Med. 2006 ; 13 (4). 225-229 (Pubitemid 44510265)
2. Ramirez P, Garcia MA, Ferrer M, et al. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J. 2008 ; 31 (2). 356-362
3. Krüger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J. 2008 ; 31 (2). 349-355
4. Delèvaux I, André M, Aumaître O, Bègue RJ, Colombier M, Piette JC. Procalcitonin measurement for differential diagnosis between pulmonary embolism and pneumonia. Crit Care Med. 2003 ; 31 (2). 1-3
5. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA. 1990 ; 263 (20). 2753-2759
6. Value of the ventilation/perfusion scan in acute pulmonary embolism. JAMA. 1990 ; 263 (20). 2753-9
7. Schoepf UJ, Goldhaber SZ, Costello P. Spiral computed tomography for acute pulmonary embolism. Circulation. 2004 ; 109 (18). 2160-2167 (Pubitemid 38625390)
8. Bartlett JG, Dowell SF, Mandell LA, File TM, Muscher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis. 2000 ; 31 (2). 347-382 (Pubitemid 32289567)
9. Kokturk N, Demir N, Oguzulgen IK, Demirel K, Ekim N. Fever in pulmonary embolism. Blood Coagul Fibrinolysis. 2005 ; 16 (5). 341-347 (Pubitemid 41008741)
10. Becker LK, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008 ; 36 (3). 941-952
11. Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J. 2007 ; 30 (3). 556-573 (Pubitemid 351182082)
12. Moscovitz H, Shofer F, Mignott H, Behrman A, Kilpatrick L. Plasma cytokine determinations in emergency department patients as a predictor of bacterimia and infectious disease severity. Crit Care Med. 1994 ; 22 (7). 1102-1107 (Pubitemid 24219415)
13. Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Froland SS. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologic parameters. J Infect Dis. 1994 ; 169 (2). 420-424 (Pubitemid 24045606)
14. Stein PD, Afzal A, Henry JW, Villareal CG. Fever in acute pulmonary embolism. Chest. 2000 ; 117 (1). 39-42 (Pubitemid 30053617)
15. Wakefield TW, Strieter RM, Prince MR, Downing LJ, Greenfield LJ. Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg. 1997 ; 5 (1). 6-15 (Pubitemid 27219718)
16. Wakefield TW, Greenfield LJ, Rolfe MW, et al. Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis. Thromb Haemost. 1993 ; 69 (2). 164-172 (Pubitemid 23041188)
17. Chooi CC, Gallus AS. Acute phase reaction, fibrinogen level and thrombus size. Thromb Res. 1989 ; 53 (5). 493-501 (Pubitemid 19114483)
18. Taheri SA, Shenoy SS, Mousa S. Circulating soluble tumor necrosis factor receptor as a marker for diagnosis of pulmonary embolus. J Med. 2001 ; 32 (3-4). 163-168 (Pubitemid 32899509)
19. Taheri SA, Lazar L, Haddad G, Castaldo R, Wilson M, Mousa S. Diagnosis of deep venous thrombosis by use of soluble necrosis factor receptor. Angiology. 1999 ; 50 (1). 85-86 (Pubitemid 29066419)
20. Mathias O, Waheedullah K, Andreas MH, Dirk B, Johannes F, Konrad R. Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-[alpha] and interleukin-6 in patients with sepsis. Crit Care Med. 1999 ; 27 (9). 1814-1818
21. Roumen-Klappe EM, den Heijer M, Van Uum SH, van der Ven-Jongekrijg J, van der Graaf F, Wollersheim H. Inflammatory response in the acute phase of deep vein thrombosis. J Vasc Surg. 2002 ; 35 (4). 701-716
22. Fox EA, Kahn SR. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost. 2005 ; 94 (2). 362-365 (Pubitemid 41122491)
23. Poredos P, Jezovnik MK. The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis. Int Angiol. 2007 ; 26 (4). 306-311 (Pubitemid 351227733)
24. Calbo E, Alsina M, Rodríguez-Carballeira M, Lite J, Garau J. Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone. Antimicrob Agents Chemother. 2008 ; 52 (7). 2395-2402 (Pubitemid 351915668)
25. Lee YL, Chen W, Chen LY, et al. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia. J Crit Care. 2010 ; 25 (1). 176e.7-176e.13
26. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004 ; 39 (2). 206-217 (Pubitemid 38971491)
27. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics. 2003 ; 112 (5). 1054-1060 (Pubitemid 37339556)
28. Christ-Crain M, Morgenthaler NG, Stolz D, et al. Proadrenomedullin to predict severity and outcome in community-acquired pneumonia. Crit Care. 2006 ; 10 (3). 96-103
29. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004 ; 363 (9409). 600-607 (Pubitemid 38264177)
30. Muller B, Peri G, Doni A, et al. High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol. 2002 ; 72 (4). 643-649 (Pubitemid 36277834)